Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
T. Takenouchi
Observed name:
Tatsuya Takenouchi
Institution:
Niigata Cancer Center Hospital
Observed institution:
Niigata Cancer Center Hospital
ORCID:
0000-0002-6818-944X
Observed ORCID:
0000-0002-6818-944X
OpenAlex ID:
A5079872109
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol
2026
·
Taku Fujimura
, Koji Yoshino
, et al.
·
Experimental Dermatology
·
2
PDF
Adjuvant therapy with locoregional interferon-beta versus surgery alone for resected stage II/III cutaneous melanoma: A multicenter randomized phase III trial (JCOG1309, J-FERON)
2026
·
K. Namikawa
, D. Ogata
, et al.
·
EJC Skin Cancer
PDF
886 Genetic and pathological analysis of schwannomatosis and schwannoma to clear the hybrid schwannoma/neurofibroma tumor
2023
·
T. Katsumi
, R. Hayashi
, et al.
·
Journal of Investigative Dermatology
PDF
157 Analysis of the hybrid schwannoma and neurofibroma including a case report of schwannomatosis caused by a mutation in the LZTR1 gene
2022
·
R. Hayashi
, T. Katsumi
, et al.
·
Journal of Investigative Dermatology
PDF
411P Ageing of skin cancer patients: a single-institution survey in Japan
2016
·
A. Sakai
, K. Kagoyama
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type